Market closed· · INR · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Total return, dividends included.
Where the price sits against its 50- and 200-day moving averages.
Makkler Fair Value, financial health score, analyst view, peers and MakklerAI.
Management targets EBITDA breakeven by Q4 FY27 despite elevated marketing costs and temporary margin pressure.
Zota Health Care Ltd (NSE:ZOTA) reports a remarkable 98.2% YoY revenue increase, driven by strategic store expansions and robust customer engagement.
Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.